| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.78B | -3.7% |
| Cost of Revenue | $1.29B | -1.3% |
| Gross Profit | $492.4M | -9.3% |
| R&D Expense | $51.0M | +6.7% |
| SG&A Expense | $285.1M | -9.2% |
| Operating Income | $129.5M | -27.2% |
| Interest Expense | $0 | — |
| Pre-tax Income | $138.1M | +235.2% |
| Income Tax | $21.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $292.5M | +1.1% |
| Accounts Receivable | $342.3M | +0.2% |
| Inventory | $329.3M | +9.4% |
| Current Assets | $1.00B | +5.0% |
| Total Assets | $1.83B | +5.6% |
| Current Liabilities | $360.1M | -3.0% |
| Total Liabilities | $499.5M | -3.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $138.3M | -25.0% |
| Capital Expenditures | $50.3M | +21.5% |
| Investing Cash Flow | -$75.1M | -21.1% |
| Financing Cash Flow | -$63.9M | -81.0% |
| Free Cash Flow | $88.0M | -38.5% |
| +283.9% |
| Net Income | $116.6M | +227.5% |
| EPS (Basic) | $4.69 | +228.0% |
| EPS (Diluted) | $4.67 | +228.9% |
| Stockholders' Equity |
| $1.33B |
| +9.5% |